What Is Pramiracetam?
Pramiracetam is a synthetic, fat-soluble racetam nootropic derived from piracetam, the original compound in the racetam family. It was developed in the late 1970s and shares the core 2-pyrrolidinone ring common to all racetams. In a few countries it is sold as a prescription medicine under the brand name Pramistar (also known by its research code CI-879), where it has been marketed for age-related memory problems. It is often described as one of the more potent racetams by weight.
What It’s Used For
In the nootropic community, pramiracetam is taken for memory, learning, and sustained focus. Historically it was studied in cognitive and memory contexts, including age-related memory decline and recovery after brain injury, which is the basis for its use as a medicine in the countries where it is approved.
It is worth separating the marketing from the evidence: the human research is thin and dated, and much of what is claimed online outruns what has actually been demonstrated. In the United States, pramiracetam is not an approved drug and is not a permitted dietary-supplement ingredient — it is sold and used in a regulatory grey area rather than as a vetted supplement.
How It Works
Pramiracetam is thought to work mainly by enhancing high-affinity choline uptake in the hippocampus, a brain region central to memory. By increasing how much choline neurons take up, it may raise the raw material available for making acetylcholine, a neurotransmitter tied to learning and memory. It does not appear to act directly on neurotransmitter receptors.
Because it is fat-soluble, it is absorbed better when taken with dietary fat. The exact mechanism is not fully established, and the details of how it produces its reported effects remain incompletely understood.
Dosage
Common community ranges are around 600 mg twice a day or 400 mg three times a day, usually totalling roughly 1,200 mg per day and taken with food that contains some fat. Many users also pair it with a choline source.
These figures reflect general community practice, not a personal recommendation. Because long-term human data is limited and pramiracetam is unapproved as a supplement, anyone considering it should be cautious and speak with a qualified health professional.
Safety
Long-term human safety data for pramiracetam is limited. Reported side effects are generally mild and include headache (often linked to choline demand, which is why users pair it with a choline source) and occasional irritability. Its regulatory status matters here: it is not an approved drug or dietary supplement in the US, so product quality and purity are not guaranteed.
Its safety in pregnancy and breastfeeding has not been established, so it is best avoided during pregnancy.
General overview — full cited research pending.